Latest Asx News

Western Gold Resources has made significant strides in advancing its Gold Duke Project, securing a preferred mining contractor with a deferred payment facility and raising over $1.7 million in capital to support development towards production.

Orpheus Uranium Limited has fortified its Australian uranium portfolio by acquiring the Pirie Basin Project and raising $1.25 million to fund upcoming exploration, positioning itself strongly in key uranium provinces.

Moab Minerals reports robust uranium mineralisation from its Manyoni Project in Tanzania and progresses exploration in Colorado’s Uravan Belt, supported by a recent $500k capital raise.

OncoSil Medical has reported a remarkable 233% increase in dose sales for Q3 FY25, alongside significant regulatory approvals and strategic expansions that position the company for accelerated growth.

Pantera Lithium has identified six high-priority drilling locations for its Smackover Lithium Brine Project, supported by promising Arkansas legislation offering fiscal and regulatory incentives that could reshape the project's economics.

Far Northern Resources has secured approval for a major drilling program at Bridge Creek and submitted a renewal for its Empire mining lease, maintaining a robust cash position after modest exploration spending in Q1 2025.

Estrella Resources is set to commence the first-ever minerals drilling program in Timor-Leste, backed by strong manganese assay results and a recent $3.75 million capital raise. The company has secured key environmental approvals and community support, positioning itself at the forefront of exploration in this emerging jurisdiction.

Core Energy Minerals has expanded its uranium portfolio with key South Australian acquisitions and secured $3.7 million in funding, setting the stage for maiden drilling at the Cummins Project.

Chilwa Minerals advances its critical minerals exploration with over 3,000 metres drilled at key deposits, a strategic assay lab shift to South Africa, and expanded local lab operations to support growing activity.

Paradigm Biopharmaceuticals has secured ethics approval and appointed a CRO to launch its global phase 3 trial for injectable Pentosan Polysulfate Sodium in knee osteoarthritis, while initiating a substantial capital raising program.

Strike Resources has made significant strides in advancing its Apurimac Iron Ore Project in Peru, engaging closely with government officials and infrastructure partners to secure critical logistics and permitting milestones. Meanwhile, its stake in Lithium Energy Limited sees progress amid asset sales and spin-out plans.

Tribune Resources delivered steady gold output and continued underground development in the March 2025 quarter, while improving cost efficiency and maintaining positive cash flow. Exploration drilling at key prospects promises potential resource upgrades ahead.